The protein p22-phox is one of two membrane-bound subunits of cytochrome b 558 (the other is gp91-phox), and mutations in the p22-phox gene (CYBA, located at 16q24, OMIM *608508) account for about 6% of CGD (Table 1) . Also about 6% of CGD cases are caused by mutations in the gene for p67-phox (NCF2, 1q25, OMIM *608515), a cytosolic component of the superoxide-generating NADPH oxidase system ( Table 2 ). The most common form of autosomal recessive CGD (about 20% of all cases) is caused by mutations in the gene for p47-phox (NCF1, 7q11.23, OMIM *608512), a second cytosolic component of the enzyme (Table 3) . Only one patient has been described with mutations in NCF4 (22q13.1, OMIM *601488), the gene encoding p40-phox, the third cytosolic NADPH oxidase component (Table 4 ). The type, position and number of the mutations in these four genes is depicted in figure 1 . Tables 5-8 list apparently benign polymorphisms that have been identified in the CYBA, NCF2, NCF1 and NCF4 genes, respectively. It is important to realize that SNPs and other sequence variants available on the internet are not necessarily functionally neutral.
Unlike the other autosomal recessive and X-linked forms of the disease, in which there is a large heterogeneity among mutations, a single defect accounts for the vast majority of cases of p47-phox-deficiency. Of ∼250 patients investigated worldwide at the DNA level, all but 53 patients in 42 families appear to be homozygous for a dinucleotide (GT) deletion (ΔGT) at the start of exon 2 (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Of the 42 families with exceptions, 20 had patients who were compound heterozygotes for the GT deletion and one additional mutation, and the others had patients with mutations other than ΔGT on both alleles of NCF1 (20 homozygous, 2 compound heterozygous). The ΔGT-bearing allele of NCF1 is therefore the most common CGD-causing allele in the population, carried by approximately 1 in 250 individuals. The reason for this predominance is that most normal individuals have two p47-phox pseudogenes, each of which co-localizes with the functional gene to 7q11.23 and carries ΔGT. Recombination events between NCF1 and these highly homologous pseudogenes lead to the incorporation of ΔGT into NCF1 (7, 20) .
Additional information about the tabulated mutations and about CGD in general can be found in recent reviews (21) (22) (23) (24) (25) and in the cited literature. In the following tables we have used the standard notation for differentiating the various phenotypes of CGD (e.g., A22°, A22 + , A67°, A67 + , A67 − , A47°, A40° and A40 + ). In this nomenclature the first letter refers to the mode of inheritance (autosomal recessive), the numeral indicates the phox component affected, and the superscript symbol indicates whether the protein is absent (°), diminished ( − ) or normal ( + ), based on immunoblot analysis. When this information is unavailable, that has been indicated as ( ? ). The respective proteins can be non-functional, exert residual activity, or in case of ( − ) be fully functional. Online Mendelian Inheritance in Man (OMIM) numbers for A22, A67, A47 CGD are #233690, #233710, and #233700, respectively. Mutations added since the last updated versions of Tables 1-3 were published (1) are marked with an asterisk in the right hand column. The nucleotide numbering system we have used is based on the cDNA sequence and follows the convention that +1 is the A of the ATG initiator codon. This differs from the numbering of the GenBank sequences; for p22-phox (GenBank accession nos. M21186 and J03774) subtract 28 from the GenBank sequence number to make the initiator A +1; for p67-phox (accession no. M32011) subtract 67 from the GenBank numbering; for p47-phox (GenBank accession nos. M25665 and M26193) subtract 12 from the GenBank numbering, and for p40-phox (accession no. NM_000631) subtract 184 from the GenBank numbering. The notation of the mutations and polymorphisms follows the recommendations of the Human Genome Variation Society (26) (see also www.hgvs.org/mutnomen). Where possible we have cross-referenced the mutations listed here with those in three CGD databases that list CGD patients by accession number. These databases contain additional biochemical, genetic and clinical information and are available at http://www.uta.fi/imt/bioinfo/CYBAbase/ (or NCF1base/, or NCF2base/). In addition, information can also be found in the HGMD database at http:// www.hgdm.cf.ac.uk/ac.search.php. The consequences of the mutations for protein composition have been checked with the Mutalyzer program (www.lovd.nl/mutalyzer) (27). Mutations in the p22-phox gene CYBA. Mutations in the p67-phox gene NCF-2. A67°4 (7) [46], unpubl. c Activation of cryptic donor splice site in intron 2, leading to incorporation of 73 nucleotides from the 5′ side of intron 2 into mRNA, including the mutated G>A at position +1 of intron 2. At the protein level, this mutation predicts incorporation of 24 aberrant amino acids after His51, followed by a stop codon at position 76 [14] .
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In addition, these patients show evidence of mRNA for p47 phox from which the last 22 bp at the 3′ region of exon 6 has been skipped (r.552_574del), as well as mRNA in which intron 6 has been included and in which the mutated exon 6 is expressed (r.[intron6+1_exon6-1ins; 574 g>a]) [14] . Mutations in the p40-phox gene NCF4. 
